Staphylococcus aureus 4-antigen vaccine + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Staphylococcal Infections
Conditions
Staphylococcal Infections
Trial Timeline
Jun 1, 2015 → Sep 1, 2016
NCT ID
NCT02492958About Staphylococcus aureus 4-antigen vaccine + Placebo
Staphylococcus aureus 4-antigen vaccine + Placebo is a phase 2 stage product being developed by Pfizer for Staphylococcal Infections. The current trial status is completed. This product is registered under clinical trial identifier NCT02492958. Target conditions include Staphylococcal Infections.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02492958 | Phase 2 | Completed |
Competing Products
20 competing products in Staphylococcal Infections